Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2019 Filed Jul 2, 2019 16:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 20 | $81.29 | $1,625.80 |
DisclosureSEC source: 0001127602-19-023376 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 14:28 UTC |
Kuyper DirkDirector
|
SaleCommon Stock | 8,970 | $83.00 | $744,467.84 |
DisclosureSEC source: 0001127602-19-021915 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.37 to $84.215. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:04 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 265 | $83.69 | $22,177.59 |
DisclosureSEC source: 0001127602-19-021324 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:07 UTC |
Lande Jerome J.Director
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020750 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:07 UTC |
Lande Jerome J.Director
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020750 · form4.xml · derivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:54 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020738 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:54 UTC |
Bronson David M.Director
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020738 · form4.xml · derivative · entry 3 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:13 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:13 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:11 UTC |
TRYNISKI MARK EDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,886 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020753 · form4.xml · derivative · entry 4 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,886 Underlying: Common Stock · 2,886 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:11 UTC |
TRYNISKI MARK EDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,876 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020753 · form4.xml · derivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,876 Underlying: Common Stock · 1,876 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:03 UTC |
Kuyper DirkDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:03 UTC |
Kuyper DirkDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:00 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:00 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:57 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:57 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:49 UTC |
Aronson Martha GoldbergDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020735 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:49 UTC |
Aronson Martha GoldbergDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020735 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · nonDerivative · entry 6 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,264 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · nonDerivative · entry 5 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,264 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · nonDerivative · entry 4 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · daughter Disclosed balance after: 200 F1 · kind: This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · nonDerivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,364 F1 · kind: This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:49 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020505 · form4.xml · derivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 520 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:49 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020505 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · derivative · entry 6 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 195 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · derivative · entry 5 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 195 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 147 | $80.48 | $11,830.56 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · nonDerivative · entry 4 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665 Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · nonDerivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 96 | $80.48 | $7,726.08 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,512 Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020500 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:34 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020489 · form4.xml · derivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 520 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:34 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 255 | $80.48 | $20,522.40 |
DisclosureSEC source: 0001127602-19-020489 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,173 Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:34 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020489 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:54 UTC |
Bronson David M.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020738 · form4.xml · derivative · entry 2 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:54 UTC |
Bronson David M.Director
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020738 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:13 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:13 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:11 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,172 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020753 · form4.xml · derivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,172 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:11 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 2,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020753 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:03 UTC |
Kuyper DirkDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:03 UTC |
Kuyper DirkDirector
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:00 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:00 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:57 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:57 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:49 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020735 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:49 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020735 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · derivative · entry 7 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 650 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 19:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 325 | $80.48 | $26,156.00 |
DisclosureSEC source: 0001127602-19-020674 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,464 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.